No profile data available.
LeMaitre Vascular, Inc. (LMAT) is a healthcare company in the targeted healthcare equipment industry, based in Burlington, United States, with about 646 full-time employees.
It reported revenue of $249.60 million for fiscal year 2025, up 13.5% from fiscal year 2024, and net income of $57.73 million. United States was its largest region in fiscal year 2025, with 57% of revenue. Its market capitalization was $1.85 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific.
LeMaitre Vascular reported $249.60 million in revenue for fiscal year 2025, up 13.5% from $219.86 million in fiscal year 2024.
United States: 57% of revenue by region in fiscal year 2025, followed by Other Countries (25%).
$1.85 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Lantheus Holdings, Inc. (LNTH), Axogen, Inc. (AXGN), Inspire Medical Systems, Inc. (INSP), NovoCure Limited (NVCR).